P152 The role of FDG-PET/CT in follow-up
✍
M. Csóka; B. Szatmáry; J. M¨uller; H. Erlaky; I. Haltrich; G. Kovács
📂
Article
📅
2007
🏛
Elsevier Science
🌐
English
⚖ 49 KB
have transfusion necessity, after the 3 month interval from the beginning of the therapy; in 14% of patients Erythropoietin was used to correct the anemic syndrome. The dosage was 10000 IU 3 times per week subcutaneous. Since no severe granulocytopenia cases were reported the administration of GM-CS